The slip
PARKINSON RECEIPTno. 9899
25 Oct 2026, 16:22 UTCdopamine neurons, braak
predictionCPA3 in dopamine neurons tracks Braak Lewy-body stage
registered3849794002061a0c
discovery+0.40 p=0.285 n=9
replication+0.63 p=0.068 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.40, p 0.285)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT8b6a17572bb2a00399e08db9…
follows 4a99346d034e…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 9899: CPA3 in dopamine neurons, braak
- power
- full sample +0.42 (p 0.082, n 18), 95% CI -0.06 to +0.74. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.44 (p 0.069, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.37 (p 0.132, n 18). could be the mix.
- skeptic
- leave-one-out range +0.34 to +0.53, sign flips 0; without severely affected donors +0.42 (p 0.082, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for CPA3 in dopamine neurons.
case closed: nothing better to follow up.